Interestingly, there are many other cancer types showing certain correlation between prognosis and SLC2A5 expression, including blood cancer, breast cancer, colorectal cancer, and eye cancer (Figures 3(e)–3(h)). The gene discussed is SLC2A5; the disease is hematopoietic and lymphoid system neoplasm.